Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 525 of 994 entries
View as:
Phase: N/A
Priority: Normal
Start: 08/01/04
End: 07/01/09
Due: 07/01/10
Phase: N/A
Priority: Normal
Start: 12/31/99
End: -
Due: -
Phase: N/A
Priority: Normal
Start: 12/31/09
End: 04/30/12
Due: 04/30/13
Phase: N/A
Priority: Normal
Start: 07/31/03
End: 02/28/06
Due: 02/28/07
Phase: N/A
Priority: Normal
Start: 09/30/10
End: 12/31/11
Due: 12/31/12
Phase: N/A
Priority: Normal
Start: 07/26/18
End: 03/28/22
Due: 03/28/23
Phase: N/A
Priority: Normal
Start: 03/13/17
End: 03/04/22
Due: 03/04/23
Phase: N/A
Priority: Normal
Start: 06/30/08
End: 10/31/09
Due: 10/31/10
Phase: N/A
Priority: Normal
Start: 12/01/21
End: 10/31/26
Due: 10/31/27
Phase: N/A
Priority: Normal
Start: 11/05/19
End: 12/01/19
Due: 12/01/20
Phase: N/A
Priority: Normal
Start: 11/13/19
End: 11/25/19
Due: 11/25/20
Phase: N/A
Priority: Normal
Start: 07/20/15
End: 03/20/17
Due: 03/20/18
Phase: N/A
Priority: Normal
Start: -
End: 11/30/03
Due: 11/30/04
Phase: N/A
Priority: Normal
Start: 12/06/19
End: 12/21/20
Due: 12/21/21
Phase: N/A
Priority: Normal
Start: 04/22/13
End: 02/19/14
Due: 02/19/15
Phase: N/A
Priority: Normal
Start: -
End: -
Due: -
Phase: N/A
Priority: Normal
Start: 08/31/04
End: 01/31/10
Due: 01/31/11
Phase: N/A
Priority: Normal
Start: 04/05/12
End: 01/31/14
Due: 01/31/15
Phase: N/A
Priority: Normal
Start: 11/30/10
End: 12/26/13
Due: 12/26/14
Phase: N/A
Priority: Normal
Start: 12/03/19
End: 12/17/19
Due: 12/17/20
Phase: N/A
Priority: Normal
Start: 11/30/11
End: 10/31/12
Due: 10/31/13
Phase: N/A
Priority: Normal
Start: 10/31/02
End: 12/31/03
Due: 12/31/04
Phase: N/A
Priority: Normal
Start: 07/31/02
End: -
Due: -
Phase: N/A
Priority: Normal
Start: 07/19/19
End: 12/17/26
Due: 12/17/27
Determination of Safe Dose of Romiplostim (AMG 531) in Patients With Myelodysplastic Syndromes (MDS)
Phase: N/A
Priority: Normal
Start: 02/28/06
End: 05/31/08
Due: 05/31/09